Philip R. Mallinder - Concepedia

Author

Philip R. Mallinder

AstraZeneca (United Kingdom)

Also Known As

P.R. Mallinder, Philip Mallinder, Philip R Mallinder, Philip R. Mallinder

Publications

706

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)Loughborough University Altimmune (United States)AstraZeneca (Sweden)

About

Philip R. Mallinder is an author at AstraZeneca (United Kingdom) specializing in medicine, immunology, and antibody engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	113
2	Engineering	1	1	264
3	Natural Sciences	1	1	264
4	Allergy	1	1	30
5	Biochemistry	1	1	264

Philip R. Mallinder

Publications

699

Citations

H-Index

Page 1

	Year	Citations
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase Elsa D. Garcin, A.S. Arvai, R.J. Rosenfeld, Nature Chemical Biology Anchored PlasticityEngineeringBiochemistryReactive Nitrogen SpecieNatural Sciences	2008	264
Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease Andrew Churg, Caroline Marshall, Don D. Sin, American Journal of Respiratory and Critical Care Medicine	2011	107
Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2 David Nicholls, Nick P. Tomkinson, Katherine Wiley, Molecular Pharmacology	2008	84
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors Ani Sarkis Balmanoukian, Jeffrey R. Infante, Raid Aljumaily, Clinical Cancer Research	2020	53
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist Rebecca Leyland, Amanda Watkins, Kathy Mulgrew, Clinical Cancer Research	2017	50
Whole-Molecule Antibody Engineering: Generation of a High-Affinity Anti-IL-6 Antibody with Extended Pharmacokinetics Donna K. Finch, Matthew A. Sleeman, Jacques Moisan, Journal of Molecular Biology Immunocytochemical TechniqueHigh-affinity Anti-il-6 AntibodyMedicineWhole-molecule Antibody EngineeringImmunology	2011	44
Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis Wendy J. Lawley, Heather Hird, Philip R. Mallinder, Mutation research. Fundamental and molecular mechanisms of mutagenesis AsthmaAllergyMedicineReal-time PcrImmunology	2005	30
Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1 Katherine A. Vousden, T. Lundqvist, Bojana Popovic, Scientific Reports	2019	28
Engineering a High-Affinity Anti-IL-15 Antibody: Crystal Structure Reveals an α-Helix in VH CDR3 as Key Component of Paratope David C. Lowe, S. Gerhardt, Alison Ward, Journal of Molecular Biology Crystal StructureVh Cdr3ImmunologyTumor ImmunityMolecular Biology	2010	21
E. coli expression and purification of human and cynomolgus IL-15 Alison Ward, Malcolm Anderson, Robert I. Craggs, Protein Expression and Purification CytokineProtein ExpressionMicrobial PathogensE. Coli ExpressionImmunology	2009	18

Page 1